Research of genetic predisposition to gestosis: polymorphism of genes, participating in vasoregulation of functions endothelium

Abstract

The polymorphism of the genes involved in the regulation of endothelial function - PLAT, PAI-1, ACE, eNOS and TNF-α - was studied in 122 pregnant women with pure and concomitant preeclampsia of varying severity and in 73 healthy puerperas. It was revealed that mutant genotypes of the studied genes are associated with more pronounced clinical and laboratory indicators of the severity of preeclampsia and the greatest increase in the level of markers of endothelial dysfunction. It is noted that the frequency of mutant genes and alleles varies depending on the severity of preeclampsia and the presence of background diseases characterized by the presence of endothelial dysfunction. The data obtained confirm the opinion that gestosis is a multifactorial disease with several, possibly independent, developmental pathways. The study of the polymorphism of genes regulating endothelial function contributes to the early identification of a risk group for the development of preeclampsia.

Keywords

pregnancy / polymorphism of genes / endothelium dysfunction / gestosis

References

[1] Айламазян Э. К. Неотложная помошь при экстремальных состояниях в акушерской практике. — 3-е изд. — СПб., «Издательство Н-Л» 2002. — 281 с. с ил.

[2] Баранов В. С., Баранова Е. В., Иващенко Т. Э. и др. Геном человека и гены «предрасположенности». (Введение в предиктивную медицину). — СПб., «Интермедика», 2000 — 272 с.

[3] Елисеева Ю. Е. Ангиотензин-превращающий фермент, его физиологическая роль//В-сы мед, химии. — 2001. — № 1. — С. 43-54.

[4] Супряга О. М. Роль эндотелиальной дисфункции в генезе гипертензивных состояний у беременных// Акуш. Гин. — 1995. — № 6. — С. 5-9.

[5] Bashford М. Т., Michael Т., Hefler L. et al. Angiotensinogen and endothelial nitric oxide synthase gene polymorphisms among Hispanic patients with preeclampsia//Am J. Obstet Gynecol. — 2001; 184. — P. 1345-51.

[6] Buttke T. M., Sandstrom P. A. Oxidative stress as a mediator of apoptosis//Immunol. Today. — 15 (1994). — P. 7-10.

[7] Cooper D. W., Brennecke S. P., Wilton A. N. Genetics of preeclampsia//Hypertens Pregn. — 1993; 12. — P. 1-23.

[8] Dekker G. A., Sibai В. M. Etiology and pathogenesis of preeclampsia: Current concepts.//Am J Obstet Gynecol. — 1998; 179. - P. 1359-75.

[9] Eriksson P., Kallin B., van’t Hooft F. M. et al. Allelespecific increase in basal transcription of the plasminogenactivator inhivitor 1 gene is associated with myocardial infarction//Proc. Natl. Acad. Sci. USA. — 1995.— Vol. 92. — P. 1851-1855.

[10] Folio M, Ginsburg D. Structure and expression of the human gene encoding plasminogen activator inhibitor, PAI-1//Gene. - 1989; 84. - P. 447-453.

[11] Glueck C. J., Phillips H., Cameron D. et al. The 4G/4G polymorphism of the hypofibrinolytic PAI-1 gene: An independent risk factor for serious pregnancy complications//Metabolism. — 49 (2000). — P. 845-852.

[12] Jaana T. M., Heiskanen M. M., Pirskanen M. J. et al. Insertion-deletion polymorphism in the gene for angiotensin-converting enzyme is associated with obstetric cholestasis but not with preeclampsia//Am J Obstet Gynecol. - 2001; 185. - P. 600-3.

[13] Katz S. D., Rao R., Berman J. et al. Pathophysiological correlates of increased serum tumor necrosis factor in patients with cingestive heart failure. Relation to nitric oxidedependent vasodilation in the forearm circulation// Circulation. - 90 (1994). - P. 12-16.

[14] Knowles R. G., Moncada S. Nitric oxide synthases in mammals// Biochem J. — 1994; 298. — P. 249-58.

[15] Lachmeijer A. M., Crusius J. B., Pals G., Dekker G. A., Arngrfmsson R., ten Kate L. P. Polymorphisms in the tumor necrosis factor and lymphotoxin-alpha gene region and preeclampsia//Obstet Gynecol. — 2001; 98. — P. 612-9.

[16] Livingston J. C., Park V., Barton J. R., Elfering S., Haddad B., Mabie W. C., et al. Lack of association of severe preeclampsia with maternal and fetal mutant alleles for tumor necrosis factor alpha and lymphotoxin alpha genes and plasma tumor necrosis factor alpha Ievels//Am J. Obstet Gynecol. — 2001; 184. — P. 1273—7.

[17] Matsumori A., Yamada T., Suzuki H. et al. Increased circulating cytokines in patients with myocarditis and cardiomyopathy//Brit. Heart J. — 72 (1994). — P. 561-566.

[18] Ness R. B., Roberts J. M. Heterogeneous causes constituting the single syndrome of preeclampsia: A hypothesis and its implications//Am J. Obstet Gynecol. — 1996; 175. - P. 1365-70.

[19] Nishikawa S., Miyamoto A., Yamamoto H., Ohshika H., Kudo R. The relationship between serum nitrate and endothelin-1 concentrations in preeclampsia//Life Sci. — 2000, Aug 11; 67( 12). - P. 1447-54.

[20] Soebbing D., Dorman K., Gregg A. R. A NOS3 polymorphism is associated with preeclampsia//Am J. Obstet Gynecol. — 1999; 180 (1 Pt 2): S18.

[21] Tempfer C., Soebbing D., Dorman K., Gregg A. R. A NOS3 polymorphism is associated with preeclampsia// Am J. Obstet Gynecol. — 1999; 180 (1 Pt 2): S18.

[22] Tuddenham E. G. D., Cooper D.N. The Molecular Genetics of Haemostasis and its Inherited Disorders. — Oxford Monographs on Medical Genetics N 25. «Oxford University Press». 1994. — 585 p.

[23] Wilson A. G., Symons J. A. et al. Effects of a polymorphism in the human TNF-α promoter on transcriptional activation//PNAS. — 1997. — Vol. 94 — P. 3195-3199.

[24] Yamada N., Arinami T., Yamakawa-Kobayashi K. et al. The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is assotiated with severe preeclampsia// J. Hum. Genet. — 45 (3), 2000. — P. 138-41.

[25] Zhao Y., Zhang W., Wang L. [Changes of plasma nitric oxide and endothelin levels in normal pregnant women and pregnancy induced hypertension]// Zhonghua Yi Xue Za Zhi. - 1998 Jun; 78 (6). - P. 457-9.

[26] Zhou N., Yu P., Chen J. et al. [Detection of insertion/ deletion polymorphism of angiotensin converting enzymegene in preeclampsia]//Chinese. — Zhonghua Yi Xue Yi Chuan Xue Za Zhi. — 1999, Feb 10; 16 (1). — P. 29-31.

RIGHTS & PERMISSIONS

Eсо-Vector